Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer-Reference-Cited by-同舟云学术

Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer

Published:2010-04-06 Issue:12 Volume:116 Page:2884-2889
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Dominici Laura S.,Negron Gonzalez Viviana M.,Buzdar Aman U.,Lucci Anthony,Mittendorf Elizabeth A.,Le-Petross Huong T.,Babiera Gildy V.,Meric-Bernstam Funda,Hunt Kelly K.,Kuerer Henry M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference19 articles.

1. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer;Fisher;J Clin Oncol.,1998

2. Overview of National Surgical Adjuvant Breast Project neoadjuvant chemotherapy studies;Mamounas;Semin Oncol.,1998

3. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy;Kuerer;J Clin Oncol.,1999

4. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy;Kuerer;Ann Surg.,1999

5. Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer;Buzdar;J Clin Oncol.,2005

Cited by 202 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-invasive prediction of axillary lymph node dissection exemption in breast cancer patients post-neoadjuvant therapy: A radiomics and deep learning analysis on longitudinal DCE-MRI data;The Breast;2024-10

2. Retrieval of the Clipped Axillary Lymph Node and Its Impact on Treatment Decisions;Cancers;2024-08-29

3. Residual Nodal Burden After Neoadjuvant Chemotherapy in cN1 Breast Cancer Patients with Positive Nodes at Targeted Axillary Dissection;Annals of Surgical Oncology;2024-07-23

4. De-escalation of Axillary Surgery After Neoadjuvant Therapy;Clinical Breast Cancer;2024-07

5. The Impact of Neoadjuvant Chemotherapy on Axillary Surgical Management of Patients With Breast Cancer and Positive Axillary Lymph Nodes;Anticancer Research;2024-04-27